Investing Profile

Ansbert Gadicke

VCInvestor

Managing Director at MPM Capital

mpmcapital.com/team/Boston, Massachusetts

Your Intro Paths to Ansbert Gadicke

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Ansbert Gadicke on

Current Investing Position

MPM Capital Managing Director

Investment Range

$1M - $150.0M

Sweet Spot

$25.0M

Investments On Record

Current Fund Size

$100M

Ansbert Gadicke is on these Sector & Stage Rankings

Ansbert Gadicke's Investments On Record (14)

Company	StageDateRound Size	Total Raised
K2 Therapeutics	SeedAug 2026$50M	$50M
Reunion Neuroscience	Series ASep 2025$130M	$130M
ElevateBio	Series DMay 2023$400M Series AMay 2019$150M	$1.1B
Co-investors: Deep Nishar (General Catalyst)
ReNAgade Therapeutics	Series AMay 2023$300M	$300M
Orna Therapeutics	Series BAug 2022$220M Series AFeb 2021$80M SeedJan 2020$20M	$320M
Co-investors: Shinichiro Fuse (TPG Biotech), Sakae Asanuma (Astellas Pharma US)
ITeos Therapeutics	Series BJun 2018$75M	$200M
Co-investors: Derek DiRocco (RA Capital Management)
TCR2	Series BMar 2018$130M Series ADec 2016$45M	$170M
Co-investors: Patrick Baeuerle (MPM Capital), Wei Li (6 Dimensions Capital)
Chiasma	Series EFeb 2015$70M Series DJul 2012$39M Series CNov 2006$44M	$160M
Co-investors: Scott Minick (ARCH Venture Partners), Bard Geesaman (Barron Park Association), Todd Foley (MPM BioImpact), Vincent Miles (Abingworth)

Investors who invest with Ansbert Gadicke

Scouts & Angels Affiliated With Ansbert Gadicke